Initial binding of murine leukemia virus particles to cells does not require specific Env-receptor interaction.
about
Charged polymers modulate retrovirus transduction via membrane charge neutralization and virus aggregationEarly steps of retrovirus replicative cycleTransmembrane Domains of Hepatitis C Virus Envelope Glycoproteins: Residues Involved in E1E2 Heterodimerization and Involvement of These Domains in Virus EntryMutagenesis of the fusion peptide-like domain of hepatitis C virus E1 glycoprotein: involvement in cell fusion and virus entryMutational analysis of the hepatitis C virus E1 glycoprotein in retroviral pseudoparticles and cell-culture-derived H77/JFH1 chimeric infectious virus particlesThe Gag cleavage product, p12, is a functional constituent of the murine leukemia virus pre-integration complexIsomerization of the intersubunit disulphide-bond in Env controls retrovirus fusion.Matrix fibronectin binds gammaretrovirus and assists in entry: new light on viral infections.Directional spread of surface-associated retroviruses regulated by differential virus-cell interactions.Lymphocyte display: a novel antibody selection platform based on T cell activationRapid dissociation of HIV-1 from cultured cells severely limits infectivity assays, causes the inactivation ascribed to entry inhibitors, and masks the inherently high level of infectivity of virions.The fusion-controlling disulfide bond isomerase in retrovirus Env is triggered by protein destabilization.Separable mechanisms of attachment and cell uptake during retrovirus infection.Activation of a cell entry pathway common to type C mammalian retroviruses by soluble envelope fragmentsEntry kinetics and cell-cell transmission of surface-bound retroviral vector particles.A unique heparin-binding domain in the envelope protein of the neuropathogenic PVC-211 murine leukemia virus may contribute to its brain capillary endothelial cell tropism.Efficient cell infection by Moloney murine leukemia virus-derived particles requires minimal amounts of envelope glycoprotein.CD4-Negative cells bind human immunodeficiency virus type 1 and efficiently transfer virus to T cellsKinetic analyses of the surface-transmembrane disulfide bond isomerization-controlled fusion activation pathway in Moloney murine leukemia virusRelationship between SU subdomains that regulate the receptor-mediated transition from the native (fusion-inhibited) to the fusion-active conformation of the murine leukemia virus glycoprotein.Expression of HIV receptors, alternate receptors and co-receptors on tonsillar epithelium: implications for HIV binding and primary oral infection.Abrogation of Ref1 retrovirus restriction in human cellsThe receptors for gibbon ape leukemia virus and amphotropic murine leukemia virus are not downregulated in productively infected cellsStructural analyses of purified human immunodeficiency virus type 1 intracellular reverse transcription complexes.Minimal exclusion of plasma membrane proteins during retroviral envelope formation.Naturally Occurring Polymorphisms of the Mouse Gammaretrovirus Receptors CAT-1 and XPR1 Alter Virus Tropism and Pathogenicity.The Trojan exosome hypothesisA mutant retroviral receptor restricts virus superinfection interference and productive infection.Polyclonal immunoglobulin G from patients neutralizes human immunodeficiency virus type 1 primary isolates by binding free virions, but without interfering with an initial CD4-independent attachment of the virus to primary blood mononuclear cells.Porcine endogenous retroviruses infect cells lacking cognate receptors by an alternative pathway: implications for retrovirus evolution and xenotransplantation.Incorporation of quantum dots on virus in polycationic solution.Cell carriers for oncolytic viruses: Fed Ex for cancer therapy.Oncolytic viruses: do they have a role in anti-cancer therapy?Reduced sensitivity to human serum inactivation of enveloped viruses produced by pig cells transgenic for human CD55 or deficient for the galactosyl-alpha(1-3) galactosyl epitope.Differential resistance to cell entry by porcine endogenous retrovirus subgroup A in rodent species.Optimization of the transductional efficiency of lentiviral vectors: effect of sera and polycations.Functional analysis of recombinant respiratory syncytial virus deletion mutants lacking the small hydrophobic and/or attachment glycoprotein geneHeparin binds to murine leukemia virus and inhibits Env-independent attachment and infectionA fifteen-amino-acid TVB peptide serves as a minimal soluble receptor for subgroup B avian leukosis and sarcoma viruses.Green fluorescent protein-tagged retroviral envelope protein for analysis of virus-cell interactions.
P2860
Q24537755-5E2B59AA-440B-4205-A832-12355A5112DCQ24792862-DB7DD62C-0C9D-44BD-BE91-42579356E8BDQ27478363-3C6F0D52-7495-4471-83E5-FC1E23268C47Q27489898-EDA2A798-E464-4223-930D-2F7AF91010F6Q27490271-F62571C4-A5FC-410C-8786-3E876204CA18Q28476124-BCA86B46-5AE8-4813-8B40-5BCDB7F03C9DQ30448089-EF077F4D-3705-459E-9E0D-70D87B947E0EQ30479938-35BEF5D8-C377-4300-B424-6F458959454BQ30493648-2DB63BBF-955A-457D-88FC-045A0ABE314CQ33506415-191E87F3-9063-42E7-9A59-A875B12CBF43Q33676520-CC11C260-92E4-4241-BEA7-1ABE92B690AFQ33717680-CB1A5CA5-1AC9-4148-9375-F2FF6DAFC59EQ33787363-37EA5C3A-E7E6-439A-86F6-618962706333Q33794864-EBF41A64-CDDE-4559-AC5E-8D15828CC86CQ33831103-14B5AD69-F261-4E61-94EE-E6B54C6BC611Q33870554-D945FE1B-E436-433B-B974-5B4C77940B95Q33874144-150C0B7F-5557-440F-B07D-14950A569BF0Q33874273-62D877BE-919E-4C82-9C2E-B47F32F2A237Q34124095-7BF3624E-B0FE-4164-B946-26C4F6A4FF5DQ34347594-6DAEF572-6FE4-4DC4-BB98-47522818355AQ34602799-694B3142-CACA-45D3-98EE-1A756A44F61EQ34970653-B483289B-F473-4E0E-90C0-DE561F5D8F77Q35105621-F6F293A5-E784-469C-BD74-0DC432F261D0Q35155063-6E8D1752-A50F-4940-83B1-E8A8FBBCAAE5Q35162499-0C79FC1F-F3F9-41BC-9985-7B665D0C1243Q35692374-2473C9E5-1A01-4D38-A858-0985521D34BCQ35976953-B1892308-757E-4CDC-92D9-6139CCA647DCQ36162599-7DC7D9A5-F154-4EC2-9501-E1EBC6DA1DE3Q36541239-09FCE2D2-97C0-4B79-8064-1B9E8F1DF0A9Q36684565-553B797A-FA92-4DA0-99F7-4A4FD4EC2355Q36717937-094CA5F1-99F1-4C58-873E-14D1CD534115Q37582184-A1B9B5FC-15C6-4B52-9F27-6016CC209762Q37926486-5B6936C1-938D-457F-94F6-7E66724BA8D8Q38341233-7F352419-05A2-4D94-985C-BC3FA4711347Q39226651-0A7D64F1-91F9-4EBE-8B34-2569A127EACEQ39381652-298A0D20-9D36-408F-939D-F06304034F68Q39603697-1A73E8F5-77F5-4C47-91B5-3034C41AEE01Q39684112-5D1752F2-12C7-4EC8-B608-C326840FBBBCQ39686823-7DF00F2A-9636-4C71-BA11-A6CFC2A2ED0FQ39748794-D2F79F92-223A-4521-B34F-850F6C3C224F
P2860
Initial binding of murine leukemia virus particles to cells does not require specific Env-receptor interaction.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
Initial binding of murine leuk ...... ific Env-receptor interaction.
@en
Initial binding of murine leuk ...... ific Env-receptor interaction.
@nl
type
label
Initial binding of murine leuk ...... ific Env-receptor interaction.
@en
Initial binding of murine leuk ...... ific Env-receptor interaction.
@nl
prefLabel
Initial binding of murine leuk ...... ific Env-receptor interaction.
@en
Initial binding of murine leuk ...... ific Env-receptor interaction.
@nl
P2093
P2860
P1433
P1476
Initial binding of murine leuk ...... cific Env-receptor interaction
@en
P2093
P2860
P304
P407
P577
1999-10-01T00:00:00Z